全球精准医疗市场

全球精准医疗市场规模预计将从2023年的542亿美元增长到2028年的1005亿美元，预测期内年复合成长率为13.2%。

按地区划分，北美市场预计将从2023年的226亿美元增长到2028年的421亿美元，年复合成长率为13.2%。欧洲市场预计将从2023年的141亿美元增长到2028年的264亿美元，年复合成长率为13.4%。

本报告调查了全球精准医疗市场，并提供了市场概况、市场影响因素和市场机会分析、市场规模趋势和预测、各个细分市场和地区的详细分析、技术趋势、ESG 发展和形势、主要企业简介等

目录

第1章简介

第2章总结/要点

第3章市场概述/定义

第4章市场动态

• 市场促进因素
• 个人化医疗需求不断增长
• 技术进步
• 政府倡议
• 慢性病患病率增加
• 市场课题
• 解释资料
• 资料隐私
• 精准医疗的成本

第5章精准医疗市场：按技术分类

• 大资料分析
• 生物信息学
• 基因测序
• 药物研发
• 伴随诊断

第6章精准医疗市场：按用途

• 瘤
• 中枢神经系统
• 免疫
• 呼吸系统疾病

第7章精准医疗市场：按地区

• 北美
• 欧洲
• 亚太地区
• 南美洲
• 中东/非洲

第8章新兴技术

第9章併购

第10章竞争资讯

• 世界公司排名

第11章公司简介

• 2BPRECISE
• ABBVIE INC.
• AMGEN INC.
• ASTRAZENECA
• BRISTOL-MYERS SQUIBB CO.
• CATALENT INC.
• CLINISYS
• F. HOFFMANN-LA ROCHE LTD.
• FABRIC GENOMICS
• HUMAN LONGEVITY INC.
• IQVIA HOLDINGS INC.
• JOHNSON & JOHNSON
• LIFEOMIC HOLDINGS LLC
• LONZA
• MERCK & CO. INC.
• NOVARTIS AG
• PAREXEL INTERNATIONAL CORP.
• PFIZER INC.
• SOPHIA GENETICS
• SYAPSE INC.
• THERMO FISHER SCIENTIFIC INC.

Highlights:

The global market for precision medicine is estimated to increase from $54.2 billion in 2023 to reach $100.5 billion by 2028, at a compound annual growth rate (CAGR) of 13.2% from 2023 through 2028.

North American market for precision medicine is estimated to increase from $22.6 billion in 2023 to reach $42.1 billion by 2028, at a compound annual growth rate (CAGR) of 13.2% from 2023 through 2028.

European market for precision medicine is estimated to increase from $14.1 billion in 2023 to reach $26.4 billion by 2028, at a compound annual growth rate (CAGR) of 13.4% from 2023 through 2028.

Report Scope:

This study offers a global view of the solutions provided by precision medicine in the market. This report analyzes and assesses technologies such as big data analytics, bioinformatics, gene sequencing, drug discovery, companion diagnostics, and others. It also provides information about the areas in which precision medicine is used, such as oncology, central nervous system disorders, immunology, respiratory conditions, and others.

BCC Research analyzes and makes projections for each market and its segmentation and assesses the regulatory environment, pipeline products, and future aspects. The report also examines the impact of COVID, discusses emerging trends in the market, and profiles leading companies in the precision medicine market such as Pfizer, Roche, AstraZeneca, Novartis, and Thermo Fisher Scientific. The report covers the major markets of North America and Europe and emerging markets such as India, China, Japan, South America, and others.

Report Includes:

• 26 tables
• A comprehensive overview and an up-to-date analysis of the global market for precision medicine
• Analyses of the global market trends, with market revenue data (sales figures) for 2020-2022, forecasts for 2023, and projections of compound annual growth rates (CAGRs) through 2028
• Discussion of industry growth driving factors and major technology issues and challenges affecting the market for precision medicine as a basis for projecting demand in the next few years (2023-2028)
• Estimation of the actual market size and revenue forecast for global precision medicine market in USD million values, and corresponding market share analysis by technology type, application, end user, and region
• Insights into the recent industry structure for precision medicine technologies, competitive aspects of each product segments, increasing investment on R&D activities, market growth strategies, and company revenue share analysis
• Review of the recent patent grants and patent applications on precision medicine technologies
• Updated information on key mergers and acquisition deals, agreements, partnerships, collaborations and product launches within the global precision medicine industry
• Identification of the major stakeholders and analysis of the company competitive landscape based on their recent developments, financial performance, and segmental revenues
• Detailed company profiles of the leading market players, including AstraZeneca, Bristol-Myers Squibb Co., Novartis AG, Pfizer Inc., and Johnson & Johnson

Table of Contents

Chapter 1 Introduction

• Study Goals and Objectives
• Reasons for Doing This Study
• Scope of Report
• Methodology
• Information Sources
• Geographic Breakdown

Chapter 2 Summary and Highlights

• Market Outlook
• Market Summary

Chapter 3 Market Overview and Definition

• Definition
• Overview

Chapter 4 Market Dynamics

• Market Drivers
• Growing Demand for Personalized Medicine
• Technological Advancement
• Government Initiatives
• Rise in Chronic Disease Prevalence
• Market Challenges
• Data Interpretation
• Data Privacy
• Cost of Precision Medicine

Chapter 5 Precision Medicine Market by Technology

• Big Data Analytics
• Bioinformatics
• Gene Sequencing
• Drug Discovery
• Companion Diagnostics

Chapter 6 Precision Medicine Market by Application

• Oncology
• Central Nervous System
• Immunology
• Respiratory Disease

Chapter 7 Precision Medicine Market by Region

• North America
• Europe
• Asia-Pacific
• South America
• Middle East and Africa

Chapter 8 Emerging Technologies

• Emerging Technology in Precision Medicine

Chapter 9 Merger and Acquisitions

• Mergers and Acquisitions

Chapter 10 Competitive Intelligence

• Global Company Ranking

Chapter 11 Company Profiles

• 2BPRECISE
• ABBVIE INC.
• AMGEN INC.
• ASTRAZENECA
• BRISTOL-MYERS SQUIBB CO.
• CATALENT INC.
• CLINISYS
• F. HOFFMANN-LA ROCHE LTD.
• FABRIC GENOMICS
• HUMAN LONGEVITY INC.
• IQVIA HOLDINGS INC.
• JOHNSON & JOHNSON
• LIFEOMIC HOLDINGS LLC
• LONZA
• MERCK & CO. INC.
• NOVARTIS AG
• PAREXEL INTERNATIONAL CORP.
• PFIZER INC.
• SOPHIA GENETICS
• SYAPSE INC.
• THERMO FISHER SCIENTIFIC INC.

List of Tables

• Summary Table : Global Market for Precision Medicine, by Region, Through 2028
• Table 1 : Global Market for Precision Medicine, by Technology, Through 2028
• Table 2 : Global Market for Precision Medicine, by Application, Through 2028
• Table 3 : Global Market for Precision Medicine, by Region, Through 2028
• Table 4 : North American Market for Precision Medicine, by Country, Through 2028
• Table 5 : North American Market for Precision Medicine, by Technology, Through 2028
• Table 6 : North American Market for Precision Medicine, by Application, Through 2028
• Table 7 : European Market for Precision Medicine, by Country, Through 2028
• Table 8 : European Market for Precision Medicine, by Technology, Through 2028
• Table 9 : European Market for Precision Medicine, by Application, Through 2028
• Table 10 : Asia-Pacific Market for Precision Medicine, by Country, Through 2028
• Table 11 : Asia-Pacific Market for Precision Medicine, by Technology, Through 2028
• Table 12 : Asia-Pacific Market for Precision Medicine, by Application, Through 2028
• Table 13 : South American Market for Precision Medicine, by Technology, Through 2028
• Table 14 : South American Market for Precision Medicine, by Application, Through 2028
• Table 15 : Middle East and African Market for Precision Medicine, by Technology, Through 2028
• Table 16 : Middle East and African Market for Precision Medicine, by Application, Through 2028
• Table 17 : Global Market Rankings for Precision Medicine, by Company, 2022
• Table 18 : Amgen Inc.: Revenue, 2020-2022
• Table 19 : AstraZeneca: Revenue, 2020-2022
• Table 20 : AstraZeneca: Revenue, by Segment (Product Sales), 2020-2022
• Table 21 : Bristol-Myers Squibb Co.: Revenue, 2020-2022
• Table 22 : Catalent Inc.: Revenue, 2020-2022
• Table 23 : Johnson & Johnson: Revenue, 2020-2022
• Table 24 : Novartis AG: Revenue, 2020-2022
• Table 25 : Pfizer Inc.: Revenue, 2020-2022

List of Figures

• Summary Figure : Global Market for Precision Medicine, by Region, 2020-2028
• Figure 1 : Global Heart and Circulatory Disease Prevalence, 2021
• Figure 2 : Big Data Analytics in Personalized Medicine
• Figure 3 : Outline of Precision Medicine in Oncology
• Figure 4 : Common Clinical Phenotypes in Neurodegenerative and Neuropsychiatric Disorders
• Figure 5 : AstraZeneca: Revenue Share, by Therapy Area, 2022
• Figure 6 : AstraZeneca: Revenue Share, by Reporting Region, 2022
• Figure 7 : Bristol-Myers Squibb Co.: Revenue Share, by Region, 2022
• Figure 8 : Novartis AG: Revenue Share, by Region, 2022
• Figure 9 : Pfizer Inc.: Revenue Share, by Country, 2022